Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
暂无分享，去创建一个
L. Risch | P. Vernazza | M. Schlegel | P. Rieder | O. Leal-Neto | S. Kuster | C. Kahlert | P. Kohler | D. Vuichard-Gysin | A. Friedl | B. Wiggli | A. McGeer | S. Guesewell | M. Seneghini | T. Egger | A. Brucher | E. Lemmenmaier | C. Moeller | M. Ruetti | R. Stocker | U. Besold